Medtronic plc — Director's Dealing 2019

Sep 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-09-27

Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-27	Ordinary Shares	S	21325	$107.511	Disposed	78916	Direct
2019-09-27	Ordinary Shares	S	100	$108.21	Disposed	78816	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.02 to $107.95, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.